SupBio
Latest round
- Series C
Last raised
- Jul 2018
Total raised
- Undisclosed
Investors
- 3
About SupBio
Based in Guangzhou, China and established in 2010, SupBio is an in vitro diagnostic product development company. It has acquired High-Tech Enterprise Certificate. It cooperates with Peking University, Zhongshan University and Peking Union Medical College Hospital, etc. The company's products mainly include HIV testing research services, HBV testing research, exosome research and TB testing research. The company generates revenue by providing and developing diagnosis kit and equipment for the treatment of epidemiology, cancer and chronic diseases.
Who invested in SupBio
3 investors across 1 round
See all investors in SupBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 30, 2018
Amount
Undisclosed
Investors
Questions about SupBio
Who invested in SupBio?
SupBio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SupBio raised?
SupBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SupBio last raise money?
SupBio's most recent round on record is a Series C, in Jul 2018.
What does SupBio do?
Based in Guangzhou, China and established in 2010, SupBio is an in vitro diagnostic product development company.
Where is SupBio headquartered?
SupBio is headquartered in Guangzhou, China.
Which VCs invest in companies like SupBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SupBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like SupBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.